Fig. 4From: Impact of autoantibodies against the M2-muscarinic acetylcholine receptor on clinical outcomes in peripartum cardiomyopathy patients with standard treatmentEndpoint events in both groups. a All-cause mortality, b cardiovascular mortality, and c rehospitalisation for heart failureBack to article page